by rdbiomed | May 26, 2020 | Company News
We’re delighted to share the news that Restech, our distribution partner in the US, has launched a branded version of our reflux diagnostic saliva test – known as ‘PepsinCheck by Peptest’. Respiratory Technology Corporation (Restech) is a leader in engineering world... 
by rdbiomed | May 18, 2020 | Company News
We’re delighted to announce that the Peptest laboratories will reopen for testing of saliva samples for pepsin on Monday 25 May. During the coronavirus pandemic we made the decision to temporarily suspend testing due to restrictions on staff movements and concerns... 
by rdbiomed | Mar 26, 2020 | Company News
In these difficult times with the Covid-19 (Coronavirus) outbreak, to protect our staff members, the majority of the RD Biomed and Peptest team will be working from home and following all of the government guidelines for the near future. We are temporarily suspending... 
by rdbiomed | Feb 14, 2020 | Company News, reflux
Peptest has been identified as a ‘promising’ way to clinically diagnose patients with non-erosive reflux disease that doesn’t respond to reflux medication. Non-erosive reflux disease (NERD) is defined as a form of gastro-oesophageal reflux disease (GERD/GORD)... 
by rdbiomed | Nov 28, 2019 | Company News
Let’s introduce you to a key member of the RD Biomed and Peptest team… Jeanine Fisher. Jeanine joined our company in 2006 and can usually be found in the Peptest laboratories at Castle Hill Hospital in Hull. As a Senior Laboratory Technician – and Project... 
by rdbiomed | Nov 21, 2019 | Company News
Peptest – a non-invasive device for diagnosing reflux disease – has been approved by Chinese health authorities and officially launched in China. The device detects the presence of pepsin (recognised as a diagnostic biomarker for reflux) in saliva samples. Leading...
Recent Comments